+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Wegener Vasculitis- Pipeline Insight, 2025 - Product Thumbnail Image

Wegener Vasculitis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Tetanus - Pipeline Insight, 2025 - Product Thumbnail Image

Tetanus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Eosinophilic Asthma - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Asthma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hyperlipidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperlipidemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ocular Graft Versus Host Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Ocular Graft Versus Host Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT2B Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2B Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT6 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT6 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
5-HT7 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT7 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-33 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-33 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Opioid Mu Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Mu Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more